Education
About Us
Working with TipRanks
Follow Us
Larimar Therapeutics, Inc. (LRMR)
NASDAQ:LRMR
LRMR Analyst Ratings
Strong Buy
10 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
LRMR Stock 12 Month Forecast
Average Price Target
$18.86
▲(941.99% Upside)
| Highest Price Target$40.00 | Average Price Target$18.86 | Lowest Price Target$10.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Robert W. Baird
Reiterated
03/25/25
Truist Financial
Reiterated
03/25/25
JonesTrading
Reiterated
03/25/25
H.C. Wainwright
Reiterated
03/25/25
Citi
Reiterated
03/25/25
Leerink Partners
Reiterated
03/24/25
William Blair
Reiterated
03/24/25
JMP Securities
Reiterated
03/24/25
Wedbush
Reiterated
03/24/25
LifeSci Capital
Reiterated
03/24/25
Oppenheimer
$26
Buy
1336.46%
Upside
Reiterated
12/17/24
Oppenheimer Reaffirms Their Buy Rating on Larimar Therapeutics (LRMR)
Guggenheim
$26
Buy
1336.46%
Upside
Reiterated
12/16/24
Guggenheim reiterates Buy Rating on Larimar Therapeutics (LRMR)Guggenheim analyst Yatin Suneja reiterated a Buy rating and $26.00 price target on Larimar Therapeutics (NASDAQ: LRMR).
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Robert W. Baird
Reiterated
03/25/25
Truist Financial
Reiterated
03/25/25
JonesTrading
Reiterated
03/25/25
H.C. Wainwright
Reiterated
03/25/25
Citi
Reiterated
03/25/25
Leerink Partners
Reiterated
03/24/25
William Blair
Reiterated
03/24/25
JMP Securities
Reiterated
03/24/25
Wedbush
Reiterated
03/24/25
LifeSci Capital
Reiterated
03/24/25
Oppenheimer
$26
Buy
1336.46%
Upside
Reiterated
12/17/24
Oppenheimer Reaffirms Their Buy Rating on Larimar Therapeutics (LRMR)
Guggenheim
$26
Buy
1336.46%
Upside
Reiterated
12/16/24
Guggenheim reiterates Buy Rating on Larimar Therapeutics (LRMR)Guggenheim analyst Yatin Suneja reiterated a Buy rating and $26.00 price target on Larimar Therapeutics (NASDAQ: LRMR).
Best Analysts Covering Larimar Therapeutics
Which Analyst Should I Follow If I Want to Buy LRMR and Sell After:
1 Month
xxx
Success Rate
13/25 ratings generated profit
Average Return
+4.64%
reiterated a xxx
rating 22 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 52.00% of your transactions generating a profit, with an average return of +4.64% per trade.
3 Months
xxx
Success Rate
12/25 ratings generated profit
Average Return
+15.18%
reiterated a xxx
rating 22 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 48.00% of your transactions generating a profit, with an average return of +15.18% per trade.
1 Year
Success Rate
12/25 ratings generated profit
Average Return
+12.68%
reiterated a buy rating 22 days ago
Copying Jonathan Wolleben's trades and holding each position for 1 Year would result in 48.00% of your transactions generating a profit, with an average return of +12.68% per trade.
2 Years
xxx
Success Rate
7/25 ratings generated profit
Average Return
+9.58%
reiterated a xxx
rating 22 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 28.00% of your transactions generating a profit, with an average return of +9.58% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
LRMR Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
11
22
20
18
12
Buy
1
1
2
1
4
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
12
23
22
19
16
Each month's total comprises the sum of three months' worth of ratings.
LRMR Financial Forecast
LRMR Stock Forecast FAQ
What is LRMR’s average 12-month price target, according to analysts?
Based on analyst ratings, Larimar Therapeutics, Inc.’s 12-month average price target is $18.86.
What is LRMR’s upside potential, based on the analysts’ average price target?
Larimar Therapeutics, Inc. has 941.99% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LRMR a Buy, Sell or Hold?
Larimar Therapeutics, Inc. has a consensus rating of Strong Buy which is based on 10 buy ratings, 0 hold ratings and 0 sell ratings.
What is Larimar Therapeutics, Inc.’s price target?
The average price target for Larimar Therapeutics, Inc. is $18.86. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $40.00 ,the lowest forecast is $10.00. The average price target represents 941.99% Increase from the current price of $1.81.
The highest analyst price target is $40.00 ,the lowest forecast is $10.00. The average price target represents 941.99% Increase from the current price of $1.81.
What do analysts say about Larimar Therapeutics, Inc.?
Larimar Therapeutics, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of LRMR?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.